Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1961-1970 of 2489 for

Edit search filters
  1. Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy

    Rochester, MN

  3. A Study to Evaluate the NanoKnife SYstem for Stage 3 Pancreatic Cancer

    Jacksonville, FL, Rochester, MN

  4. A Study to Collect Tissue Samples from Patients with Myeloproliferative Neoplasms, to Perform a Variety of Biomarker Studies

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate User Feedback Using Affirm® Contrast Biopsy

    Scottsdale/Phoenix, AZ

  6. A Study Of Biomarkers To Predict Cancer Therapy-related Cardiotoxicity

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study of Pharmacogenomics Results and Clinical Data of Patients with Chronic Myeloid Leukemia and Lung Cancer to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  8. Cardiotoxic Effects of Chemotherapy in Patients with Sarcomas

    Rochester, MN

  9. Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

    Rochester, MN

  10. A Study To Evaluate The Immune Response To Anti-HER2 Therapies

    Jacksonville, FL

.

Mayo Clinic Footer